These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6102913)

  • 1. Clinical pharmacokinetics and oral bioavailability of ketobemidone.
    Bondesson U; Arnér S; Anderson P; Boréus LO; Hartvig P
    Eur J Clin Pharmacol; 1980 Jan; 17(1):45-50. PubMed ID: 6102913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose kinetics and bioavailability of ketobemidone.
    Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
    Acta Anaesthesiol Scand Suppl; 1982; 74():59-62. PubMed ID: 6124079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
    Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
    Eur J Clin Pharmacol; 1981 Feb; 19(3):217-23. PubMed ID: 7215421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple dose kinetics of ketobemidone in surgical patients.
    Bondesson U; Tamsen A; Dahlström B; Hartvig P
    Acta Anaesthesiol Scand Suppl; 1982; 74():63-5. PubMed ID: 6124080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
    Bondesson U; Hartvig P; Danielsson B
    Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of cough after intravenous bolus injection of Ketogan (ketobemidone + N,N-dimethyl-3,3-diphenyl-1-methylallylamine chloride) for postoperative pain relief.
    Karlsten R; Hartvig P
    Acta Anaesthesiol Scand; 1992 Feb; 36(2):193-4. PubMed ID: 1549941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone.
    Tamsen A; Bondesson U; Dahlström B; Hartvig P
    Clin Pharmacokinet; 1982; 7(3):252-65. PubMed ID: 7094500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive effect of ketobemidone in comparison with Ketogin.
    Larsen JJ; Christensen AV
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):100-4. PubMed ID: 6687776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ketobemidone in critically ill patients.
    Al-Shurbaji A; Tokics L
    Br J Clin Pharmacol; 2002 Dec; 54(6):583-6. PubMed ID: 12492604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
    Kjaer M; Nielsen H
    Acta Oncol; 1988; 27(5):583-9. PubMed ID: 3203014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine.
    Wolff T; Leward S; Hagman A; Andersson M; Larsson L; Elgen K
    Acta Med Scand; 1988; 223(5):423-30. PubMed ID: 2897763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics after a single intravenous dose of the opioid ketobemidone in neonates.
    Lundeberg S; Stephanson N; Stiller CO; Eksborg S
    Acta Anaesthesiol Scand; 2012 Sep; 56(8):1026-31. PubMed ID: 22834454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple-dose, double-blind comparison of intramuscularly and orally administered ketorolac tromethamine and Ketogan in patients with pain following orthopaedic surgery.
    Gebuhr PH; Soelberg M; Strauss W
    J Int Med Res; 1994; 22(4):202-17. PubMed ID: 7958380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children.
    Lundeberg S; Stephanson N; Lafolie P; Olsson GL; Stiller CO; Eksborg S
    Acta Anaesthesiol Scand; 2010 Apr; 54(4):435-41. PubMed ID: 19839946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patient-controlled administration of analgesics--an alternative in intensive care].
    Islander G
    Lakartidningen; 1986 Oct; 83(42):3528. PubMed ID: 2878128
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist.
    Ebert B; Thorkildsen C; Andersen S
    Pharmacol Toxicol; 1998 Mar; 82(3):157-60. PubMed ID: 9553996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reflections on pain treatment].
    Moi H
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1511. PubMed ID: 9198935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioavailability and analgetic effect of sustained-release ketobemidone capsules in patients with chronic pain of cancer].
    Kjaer M; Nielsen H; Andersen LS
    Ugeskr Laeger; 1993 Mar; 155(11):783-8. PubMed ID: 8096349
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and mass spectra of deuterium-labelled ketobemidone and of some potential ketobemidone metabolites.
    Bondesson U; Danielsson B; Lindberg C
    Acta Pharm Suec; 1980; 17(1):1-11. PubMed ID: 6106995
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous determination of ketobemidone and its N-demethylated metabolite in patient plasma samples by gas chromatography mass spectrometry with selected ion monitoring.
    Bondesson U; Hartvig P; Abrahamsson L; Ahnfelt NO
    Biomed Mass Spectrom; 1983 Apr; 10(4):283-6. PubMed ID: 6133568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.